ACC 2026 | STEMI-Door To Unload: Unloading with Impella before PCI did not reduce infarct size in anterior STEMI

Anterior ST-segment elevation myocardial infarction (STEMI) remains associated with a high incidence of heart failure and mortality, even in the era of early reperfusion. The “door-to-unload” concept emerged as a physiologically appealing strategy, supported by preclinical data and a pilot study suggesting that left ventricular unloading prior to reperfusion could reduce infarct size.

Cobertura Científica SOLACI ACC 2026

The objective of the STEMI-DTU study was to evaluate whether a strategy using Impella CP, with a protocolized delay of at least 30 minutes before PCI, could reduce infarct size compared with a standard strategy of coronary angiography and immediate angioplasty in patients with acute anterior STEMI without cardiogenic shock.

This was a randomized study that included patients aged 18 to 85 years, with a first myocardial infarction, presenting between 1 and 6 hours from symptom onset, with anterior STEMI and anatomy suitable for Impella use. Patients were randomized to a strategy of Impella CP + ≥30-minute delay before PCI, with support for 4 to 24 hours, or to immediate PCI. The primary efficacy endpoint was infarct size measured by cardiac MRI between days 3 and 5, expressed as a percentage of left ventricular mass. A total of 527 patients were randomized across 55 centers.

The results showed that, in the intention-to-treat population, there were no differences in the primary endpoint: infarct size was 30.8±16.2% in the treatment group and 31.9±16.9% in the control group (95% CI -4.2 to 2.0; p=0.50). In the per-protocol analysis, no significant differences were observed either: absolute difference of -1.9% (95% CI -5.5 to 1.6; p=0.28). The hierarchical secondary endpoint also showed no benefit, with a win ratio of 1.04 (95% CI 0.84–1.28; p=0.73).

Read also: ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI.

As expected, the unloading strategy prolonged reperfusion times: there was an average increase of 47 minutes in total ischemic time and 42 minutes in door-to-balloon time, with no bailout PCI required. At 12 months, no significant differences were observed in all-cause mortality (4.0% vs 5.1%; HR 0.76; p=0.51).

Regarding safety, in the post hoc analysis of the ITT population, the composite of major bleeding or vascular complications was more frequent in the treatment group (34.0% vs 6.0%), mainly driven by access-site-related events (31.7% vs 2.3%).

Conclusions: STEMI-DTU Study Design: Impella CP with pre-PCI delay vs immediate angioplasty in anterior STEMI

The combination of Impella CP with a 30-minute delay before PCI did not reduce infarct size compared with immediate PCI in patients with anterior STEMI without shock. Major bleeding and vascular complications were more frequent in the Impella group.

Presented by Gregg W. Stone at the Late-Breaking Clinical Trials, ACC.26, March 28–30, New Orleans, USA.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

DAPT ≤30 Days After Drug-Coated Balloon Coronary Angioplasty

Drug-coated balloon (DCB) coronary angioplasty without stent implantation has become a well-established alternative in several clinical scenarios, particularly in patients at high bleeding risk...

Is IVUS Always Necessary for Left Main Coronary Artery PCI?

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery is a highly complex procedure because of the large amount of myocardium at...

Dual-Prep Registry: Atherectomy and IVL for Severe Coronary Calcification

Severe coronary calcification remains one of the most challenging scenarios in percutaneous coronary intervention (PCI). Although rotational or orbital atherectomy and intravascular lithotripsy (IVL)...

Prehospital heparin in STEMI: A safe strategy associated with improved early reperfusion

Early reperfusion remains the main prognostic determinant in patients with ST-segment elevation myocardial infarction (STEMI). Although primary percutaneous coronary intervention (PCI) is the treatment...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

SAFE-PROTECT at 12 Months: AnchorMan vs. Watchman for Left Atrial Appendage Closure

Percutaneous left atrial appendage (LAA) closure is an alternative therapeutic strategy for reducing the risk of stroke in patients with atrial fibrillation (AF). Randomized...

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

According to the latest European guidelines, transcatheter aortic valve implantation (TAVI) is the recommended treatment for patients aged ≥70 years with symptomatic severe aortic...

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...